Spin-off Overview On August 9, 2018, Perrigo (PRGO) announced that it would be separating its pharmaceutical business. Potential options include a tax free spin-off, merger, or sale. Expected timing is Q3 2019. Source: Perrigo Slide Deck Background: From WSJ: Perrigo plans to shed its prescription pharmaceutical unit, which accounts for about one-fifth of total revenue, [...]
